Unité Mixte Internationale TransVIHMI

L’UMI 233 étudie principalement les spécificités de l’infection par le VIH au Sud et ses conséquences pour les populations. L’impact du VIH sur les autres endémies infectieuses tropicales fait que le champ des recherches aborde aussi la problématique des co-infections (hépatites, tuberculose) et d’autres maladies tropicales négligées telles que les filarioses et plus récemment l'infection par le virus Ebola. Autour de cette unité thématique, et cela depuis sa création il y a près de 20 ans, l’UMI 233 mène des travaux de recherches transversales pluridisciplinaires associant virologie, parasitologie, clinique, épidémiologie, santé publique et sciences sociales. Si le VIH et les Maladies Associées restent le thème principal de l'unité, l'unité mène des travaux sur les Maladies Tropicales Négligées comme la filariose, l'infection par le virus Ebola et tout récemment l’infection par le virus SARS-CoV-2 .
Featured Dataverses

In order to use this feature you must have at least one published or linked dataverse.

Publish Dataverse

Are you sure you want to publish your dataverse? Once you do so it must remain published.

Publish Dataverse

This dataverse cannot be published because the dataverse it is in has not been published.

Delete Dataverse

Are you sure you want to delete your dataverse? You cannot undelete this dataverse.

Advanced Search

11 to 20 of 71 Results
areaone_metaanalysis_pooled_data_esbl_dictionnary.tab
Aug 4, 2025 - Replication data for: Antimicrobial resistance of Enterobacterales in Central Africa: a systematic review and meta-analysis
Tabular Data - 1.1 KB - 1 Variables, 16 Observations - UNF:6:BJ5jLVxLdazgMIWULgoC6A==
areaone_metanalysis_general_info_esbl.tab
Aug 4, 2025 - Replication data for: Antimicrobial resistance of Enterobacterales in Central Africa: a systematic review and meta-analysis
Tabular Data - 8.3 KB - 23 Variables, 25 Observations - UNF:6:VrA2ZaiekJH8Kv7xTgzvBw==
areaone_metanalysis_pooled_data_esbl.tab
Aug 4, 2025 - Replication data for: Antimicrobial resistance of Enterobacterales in Central Africa: a systematic review and meta-analysis
Tabular Data - 1.4 KB - 1 Variables, 25 Observations - UNF:6:+tb82MVYgL97rroPa9m/Mw==
ReadMe.txt
Aug 4, 2025 - Replication data for: Antimicrobial resistance of Enterobacterales in Central Africa: a systematic review and meta-analysis
Plain Text - 2.8 KB - MD5: 64124443baf848e1a6d17fcfb678019a
Dataset citation, description and terms of use
Disability and quality of life assessment using WHODAS-12 items 2.0 and EQ-5D-5L in a rural area endemic for loiasis in the Republic of Congo: a population-based cross-sectional study (the MorLo project)
Disability and quality of life assessment using WHODAS-12 items 2.0 and EQ-5D-5L in a rural area endemic for loiasis in the Republic of Congo: a population-based cross-sectional study (the MorLo project)
May 23, 2025
Chesnais, Cedric; Campillo, Jérémy; Dupasquier, Valentin; Lebredonchel, Elodie; Beneteau, Samuel; Rancé, Ludovic; Madoulou, Glorifié; Niama, Ange; Bileckot, Richard; Pion, Sébastien; Boussinesq, Michel; Missamou, François, 2025, "Disability and quality of life assessment using WHODAS-12 items 2.0 and EQ-5D-5L in a rural area endemic for loiasis in the Republic of Congo: a population-based cross-sectional study (the MorLo project)", https://doi.org/10.23708/KCEDO2, DataSuds, V1, UNF:6:fayZ8BhGmddSHb8r11mvcg== [fileUNF]
Background: Loa loa filariasis, a parasitic infection endemic to Central Africa, is a common cause of medical consultation in this region. Methods: To evaluate the quality of life (QoL) of individuals living in loiasis-endemic areas, we enrolled 991 subjects (one-third being micr...
Data_Use_Agreement_Template.pdf
Data_Use_Agreement_Template.pdf
May 23, 2025 - Disability and quality of life assessment using WHODAS-12 items 2.0 and EQ-5D-5L in a rural area endemic for loiasis in the Republic of Congo: a population-based cross-sectional study (the MorLo project)
Adobe PDF - 60.2 KB - MD5: c315b2d8e14230adeed9a06ada7b154c
Documentation
Data use agreement template. The form must be downloaded, completed and returned to the authors of the dataset and data@ird.fr before access to the data files is granted.
ReadMe_KCEDO2.txt
May 23, 2025 - Disability and quality of life assessment using WHODAS-12 items 2.0 and EQ-5D-5L in a rural area endemic for loiasis in the Republic of Congo: a population-based cross-sectional study (the MorLo project)
Plain Text - 3.2 KB - MD5: 50d40660aca5bc2534f84297b28beb6c
Documentation
Contains citation, description and conditions of use of dataset data
WHODAS_Loa_Congo_PlosNTD_Data.tab
May 23, 2025 - Disability and quality of life assessment using WHODAS-12 items 2.0 and EQ-5D-5L in a rural area endemic for loiasis in the Republic of Congo: a population-based cross-sectional study (the MorLo project)
Tabular Data - 279.1 KB - 41 Variables, 991 Observations - UNF:6:PqyFALRq3bZu/zOietLriw==
Données
Data from WHODAS 2.0 12-item and EQ-5D-5L questionnaires
WHODAS_Loa_Congo_PlosNTD_Dictionnary_Data.tab
May 23, 2025 - Disability and quality of life assessment using WHODAS-12 items 2.0 and EQ-5D-5L in a rural area endemic for loiasis in the Republic of Congo: a population-based cross-sectional study (the MorLo project)
Tabular Data - 2.5 KB - 12 Variables, 36 Observations - UNF:6:ui7L6W5QiM700BJWaUsesg==
Documentation
Data dictionnary
Replication data for Safety and efficacy of 3- and 5-day regimens of levamisole in loiasis: a randomized, placebo-controlled, double-blind clinical trial
May 23, 2025
Cédric B. Chesnais; Marlhand C. Hemilembolo; Bachiratou A. Sahm; Florentin Toutin; Ericson Djeutassong; Nadia Nga-Elomo; Benjamin Cuer; Mas A. Ntsiba-N’goulou; Miveck Pakat; Sébastien D. S. Pion; François Missamou; Michel Boussinesq; Jérémy T Campillo, 2025, "Replication data for Safety and efficacy of 3- and 5-day regimens of levamisole in loiasis: a randomized, placebo-controlled, double-blind clinical trial", https://doi.org/10.23708/TTJXSF, DataSuds, V1, UNF:6:QDTu5z2Y7xIeanRSu3mpUw== [fileUNF]
Background. Individuals with high Loa loa microfilarial densities (MFD) risk serious adverse events (SAEs) following ivermectin treatment. A single dose of levamisole (LEV) induces a temporary, progressive MFD decrease. We assessed the safety and efficacy of 3- and 5-day LEV (LEV...
Add Data

Log in to create a dataverse or add a dataset.

Log In
Share Dataverse

Share this dataverse on your favorite social media networks.

Link Dataverse
Reset Modifications

Are you sure you want to reset the selected metadata fields? If you do this, any customizations (hidden, required, optional) you have done will no longer appear.